Marquez Elena sold $341K of ATEX
Marquez Elena (Chief Financial Officer) sold 4,291 shares of Anterix Inc. (ATEX) at $79.50 ($0.34M total) on 2026-06-17.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and post-transaction holdings; it does not include any company performance, guidance, or regulatory/legal development.
Market read
Traders may monitor for clustering of insider activity, but this single sale is unlikely to drive a sustained repricing without corroborating fundamentals.
What to watch
Insider sales often reflect diversification, tax planning, or scheduled liquidity needs; without additional context (e.g., other insider buys/sales, guidance changes), directional inference is weak.
Background
This is an SEC Form 4 insider transaction disclosure for Anterix (ATEX) by CFO Marquez Elena.
Ticker impact
CFO Marquez Elena filed a Form 4 selling 4,291 shares of Anterix (ATEX) at $79.50 on 2026-06-17.
Likely limited near-term impact; any effect is typically short-lived unless paired with other negative disclosures.
The filing is an open-market sale with no 10b5-1 plan stated; however, insider sales alone are usually not a strong directional catalyst without accompanying guidance, enforcement, or material corporate events.
Market effects
Minimal—single insider transaction in a non-sector-wide context.
None indicated.
None indicated.
Counterpoint
Because the sale is by the CFO and explicitly notes no 10b5-1 plan, some traders may interpret it as a stronger signal than typical insider sales—though the article provides no rationale or follow-on actions.
Key entities
- issuerAnterix Inc.
Subject of the Form 4 insider sale disclosure (ATEX).
- insiderMarquez Elena
Chief Financial Officer who sold 4,291 shares on 2026-06-17.
